Cycloepoxydon, 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction

72Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

In a screening for new inhibitors of NF-κB and AP-1 mediated signal transduction pathways in COS-7 cells using secreted alkaline phosphatase (SEAP) as a reporter gene three novel compounds, cycloepoxydon (1), 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene (2) and 1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene (3) were isolated from fermentations of the deuteromycete strain 45-93. Cycloepoxydon inhibits the TPA-induced NF-κB and AP-1 mediated SEAP expression with an IC50 of 1 ~ 2 μg/ml (4.2 ~ 8.4 μM) and 3 ~ 5 μg/ml (12.6 ~ 21 μM) respectively. 1-Hydroxy-2-hydroxymethyl-3-pent-1-enyibenzene (2) inhibits the TPA-induced NF-κB and AP-1 mediated SEAP expression with an IC50 of 7 μg/ml (36.4 μM) and 5 μg/ml (26 μM). 3 showed only a weak inhibition of the AP-1 and no influence on NF-κB dependent reporter gene expression. In COS-7 and HeLa S3 cells electrophoretic mobility shift assays showed that cycloepoxydon strongly reduced the TPA and TNF-α mediated binding of NF-κB to a high affinity consensus sequence which was due to the inhibition of phosphorylation of the inhibitory protein IκB.

Cite

CITATION STYLE

APA

Gehrt, A., Erkel, G., Anke, T., & Sterner, O. (1998). Cycloepoxydon, 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction. Journal of Antibiotics, 51(5), 455–463. https://doi.org/10.7164/antibiotics.51.455

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free